Profile | GDS4284 / 218997_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1236.5 | 77 |
GSM687648 | Patient 402 control | 1535.37 | 80 |
GSM687653 | Patient 403 control | 1366.46 | 79 |
GSM687658 | Patient 404 control | 1058.92 | 75 |
GSM687663 | Patient 411 control | 1453.56 | 79 |
GSM687668 | Patient 422 control | 1212.15 | 77 |
GSM687673 | Patient 424 control | 1092.54 | 75 |
GSM687678 | Patient 425 control | 1436.25 | 79 |
GSM687683 | Patient 427 control | 1553.81 | 80 |
GSM687688 | Patient 428 control | 1105.54 | 76 |
GSM687695 | Patient 441 control | 890.457 | 73 |
GSM687699 | Patient 443 control | 1465.52 | 80 |
GSM687704 | Patient 444 control | 1075.08 | 75 |
GSM687707 | Patient 448 control | 1961.22 | 84 |
GSM687712 | Patient 449 control | 1384.22 | 79 |
GSM687719 | Patient 450 control | 1580.37 | 81 |
GSM687724 | Patient 451 control | 1889.96 | 84 |
GSM687728 | Patient 452 control | 1091.73 | 76 |
GSM687646 | Patient 401 treated 24h | 1188.69 | 76 |
GSM687649 | Patient 402 treated 24h | 1060.67 | 75 |
GSM687665 | Patient 411 treated 24h | 1286.27 | 78 |
GSM687651 | Patient 402 treated 4 weeks | 1736.32 | 82 |
GSM687667 | Patient 411 treated 4 weeks | 1414.66 | 79 |
GSM687670 | Patient 422 treated 24h | 1371.52 | 78 |
GSM687671 | Patient 422 treated 4 weeks | 1259.14 | 77 |
GSM687654 | Patient 403 treated 24h | 1377.05 | 79 |
GSM687675 | Patient 424 treated 24h | 1154.31 | 76 |
GSM687685 | Patient 427 treated 24h | 1716.91 | 82 |
GSM687656 | Patient 403 treated 4 weeks | 1106.14 | 75 |
GSM687677 | Patient 424 treated 4 weeks | 969.994 | 73 |
GSM687687 | Patient 427 treated 4 weeks | 1338.84 | 78 |
GSM687692 | Patient 428 treated 4h | 1057.01 | 75 |
GSM687716 | Patient 449 treated 4h | 1176.41 | 77 |
GSM687722 | Patient 450 treated 4h | 1204.33 | 77 |
GSM687680 | Patient 425 treated 24h | 1197.96 | 76 |
GSM687690 | Patient 428 treated 24h | 1018.42 | 75 |
GSM687700 | Patient 443 treated 24h | 1280.72 | 78 |
GSM687705 | Patient 444 treated 24h | 1398.15 | 79 |
GSM687714 | Patient 449 treated 24h | 1393.48 | 79 |
GSM687721 | Patient 450 treated 24h | 861.719 | 72 |
GSM687682 | Patient 425 treated 4 weeks | 1334.56 | 78 |
GSM687694 | Patient 428 treated 4 weeks | 1341.89 | 78 |
GSM687702 | Patient 443 treated 4 weeks | 1209.5 | 76 |
GSM687718 | Patient 449 treated 4 weeks | 1190.99 | 77 |
GSM687723 | Patient 450 treated 4 weeks | 1210.3 | 77 |
GSM687661 | Patient 404 treated 4h | 1085.53 | 75 |
GSM687710 | Patient 448 treated 4h | 1384.2 | 79 |
GSM687726 | Patient 451 treated 4h | 1619.57 | 81 |
GSM687730 | Patient 452 treated 4h | 2992.84 | 90 |
GSM687660 | Patient 404 treated 24h | 880.906 | 74 |
GSM687697 | Patient 441 treated 24h | 835.431 | 72 |
GSM687709 | Patient 448 treated 24h | 1322.8 | 78 |
GSM687725 | Patient 451 treated 24h | 1593.18 | 81 |
GSM687729 | Patient 452 treated 24h | 1058.92 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 1553.5 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 1287.27 | 78 |